навременен Треперете облекчение non ligand estrogen pathway nf kappa fulvestrant артерия Инфрачервен конски сили
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers | HTML
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
EREs).
New insights into acquired endocrine resistance of breast cancer
IJMS | Free Full-Text | The Role of ERα36 in Development and Tumor Malignancy | HTML
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text